PIK3CA and neoplasm: Consistent with our findings, a pooled analysis of 10,319 women with early-stage breast cancer from 19 studies showed a PIK3CA mutation rate of 32% with the detection of PIK3CA mutations significantly associated with ER-positive status, increased age, lower tumor grade, and smaller body size (all P <0.001) 28.